Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth C. Carter currently holds 21,775 shares of AVALON PHARMACEUTICALS INC (AVRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth C. Carter has been a net buyer of AVRX stock. They have purchased $28.0K and sold $8.9K worth of shares.
Kenneth C. Carter's most recent insider trade was on May 28, 2009, when they sold 23,875 shares at $0.00 per share.
Kenneth C. Carter serves as Executive at AVALON PHARMACEUTICALS INC (AVRX). They have executed 22 insider transactions totaling $36.8K over their tenure at the company.
Kenneth C. Carter holds the position of Executive at AVALON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kenneth C. Carter has shown a buying trading pattern, with $28.0K in total purchases and $8.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kenneth C. Carter was on Aug 30, 2006, when they purchased $9.0K worth of AVRX shares. This transaction involved 3,000 shares at $2.99 per share.
Kenneth C. Carter currently owns 21,775 shares of AVALON PHARMACEUTICALS INC (AVRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth C. Carter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth C. Carter has 22 Form 4 filings on record as an insider at AVALON PHARMACEUTICALS INC.
Set alerts for Kenneth C. Carter and 40,000+ other insiders.